Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have received an average rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $79.67.
ACHC has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Barclays decreased their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Finally, KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company.
Get Our Latest Report on Acadia Healthcare
Institutional Trading of Acadia Healthcare
Acadia Healthcare Stock Performance
ACHC opened at $42.16 on Monday. The business has a fifty day simple moving average of $49.09 and a 200 day simple moving average of $63.14. The company has a market capitalization of $3.92 billion, a PE ratio of 13.85, a price-to-earnings-growth ratio of 1.88 and a beta of 1.30. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the company earned $0.91 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. Research analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Consumer Discretionary Stocks Explained
- Tesla Poised to Hit Record Highs This Holiday Season
- Basic Materials Stocks Investing
- The Salesforce Rally is Just Getting Started: Here’s Why
- How to Calculate Inflation Rate
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.